Skip to Content

Fosamax Plus D Approval History

FDA Approved: Yes (First approved April 7, 2005)
Brand name: Fosamax Plus D
Generic name: alendronate and cholecalciferol
Dosage form: Tablets
Company: Merck & Co., Inc.
Treatment for: Osteoporosis

Fosamax Plus D is a single once-weekly tablet containing the bisphosphonate drug alendronate, and seven days’ worth of vitamin D, an essential nutrient required for calcium absorption. Fosamax Plus D is used to reduce the risk of hip and spinal fractures in postmenopausal women with osteoporosis, and to increase bone mass in men with osteoporosis.

Development History and FDA Approval Process for Fosamax Plus D

DateArticle
Apr  7, 2005Approval Fosamax Plus D Merck & Co., Inc. - Treatment for Osteoporosis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide